Publicaciones en colaboración con investigadores/as de Hospital Universitario de Valladolid (42)

2024

  1. Biological variability of human intraepithelial lymphocytes throughout the human gastrointestinal tract in health and coeliac disease

    European Journal of Clinical Investigation

  2. MiRNome Profiling of Extracellular Vesicles in Patients with Severe COVID-19 and Identification of Predictors of Mortality

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. 901-911

  3. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients

    Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  4. MIF is a common genetic determinant of COVID-19 symptomatic infection and severity

    QJM : monthly journal of the Association of Physicians, Vol. 116, Núm. 3, pp. 205-212

  5. Plasma levels of intestinal fatty-acid binding protein (I-FABP), abdominal distension and hydrogen concentration after lactitol small intestinal bacterial overgrowth (SIBO) test

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 12, pp. 727-728

  6. Study and isolation of human intestinal dendritic cell and macrophage subsets

    Methods in Cell Biology (Academic Press Inc.), pp. 69-76

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

  3. Metabolomics study of COVID-19 patients in four different clinical stages

    Scientific reports, Vol. 12, Núm. 1, pp. 1650

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection

    Nature Communications, Vol. 13, Núm. 1

  6. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can

    Frontiers in Immunology, Vol. 12

  2. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  3. Growth arrest-specific factor 6 (Gas6) is increased in covid-19 patients and predicts clinical outcome

    Biomedicines, Vol. 9, Núm. 4

  4. HGF, IL-1α, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  5. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477